Related Experiment Video
Updated: Jan 28, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Predictive Model for the Detection of Subclinical Atherosclerosis in HIV Patients on Antiretroviral Treatment
César Galvez-Barrón1, Sara Gamarra-Calvo2, Jose Ramon Blanco Ramos3
1Research Area, Consorci Sanitari Alt Penedés-Garraf, Barcelona, Spain.
Insights
This study developed predictive models for early atherosclerosis detection in people living with HIV (PLHIV). Easily collected clinical variables identified patients at higher cardiovascular risk, aiding early intervention.
Area of Science:
- Cardiology
- Infectious Diseases
- Medical Imaging
Background:
- Patients living with HIV (PLHIV) exhibit increased cardiovascular risk.
- Early detection of subclinical atherosclerosis is crucial for this population.
- Existing risk assessment tools may not fully capture atherosclerosis risk in PLHIV.
Purpose of the Study:
- To develop and validate predictive models for subclinical atherosclerosis in PLHIV.
- To identify easily accessible clinical variables for atherosclerosis risk prediction.
- To create a potential screening tool for early cardiovascular risk assessment in PLHIV.
Main Methods:
- Cross-sectional observational study design.
- Recruitment of PLHIV without established cardiovascular disease.
- Development of predictive models using logistic regression and machine learning techniques.
- Variables tested included sociodemographic, clinical, HIV-related, laboratory, and capillaroscopy data.
- Internal validation using bootstrapping.
Main Results:
- 19.8% of the 96 analyzed PLHIV had subclinical atherosclerosis.
- Key predictors identified: hypertension, dyslipidaemia, protease inhibitors, triglycerides, fibrinogen, and alkaline phosphatase.
- Logistic regression model achieved an AUC of 0.91 (0.80 after validation).
- Machine learning models yielded AUCs between 0.73 and 0.86.
Conclusions:
- The developed predictive models show relevant performance for subclinical atherosclerosis in PLHIV.
- Models utilize easily accessible parameters, suggesting utility as a screening tool.
- External validation in larger cohorts is recommended due to study limitations, particularly sample size.
Objective:
Patients living with HIV (PLHIV) have a higher cardiovascular risk than others, which is why the early detection of atherosclerosis in this population is important. The present study reports predictive models of subclinical atherosclerosis for this population of patients, made up of variables that are easily collected in the clinic.
Methods:
The study design is a cross-sectional observational study. PLHIV without established cardiovascular disease were recruited for this study. Predictive models of subclinical atherosclerosis (Doppler ultrasound) were developed by testing sociodemographic variables, pathological history, data related to HIV infection, laboratory parameters, and capillaroscopy as potential predictors. Logistic regression with internal validation (bootstrapping) and machine learning techniques were used to develop the models.
Results:
Data from 96 HIV patients were analysed, 19 (19.8%) of whom had subclinical atherosclerosis. The predictors that went into both machine learning models and the regression model were hypertension, dyslipidaemia, protease inhibitors, triglycerides, fibrinogen, and alkaline phosphatase. Age and C-reactive protein were also part of the machine learning models. The logistic regression model had an area under the receiver operating characteristic curve (AUC) of 0.91 (95% CI: 0.84-0.99), which became 0.80 after internal validation by bootstrapping. The machine learning techniques produced models with AUCs ranging from 0.73 to 0.86.
Conclusion:
We report predictive models for subclinical atherosclerosis in PLHIV, demonstrating relevant predictive performance based on easily accessible parameters, making them potentially useful as a screening tool. However, given the study's limitations-primarily the sample size-external validation in larger cohorts is warranted.
More Related Videos
07:06Prediction of HIV-1 Coreceptor Usage Tropism by Sequence Analysis using a Genotypic Approach
Published on: December 1, 2011
05:53Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Related Concept Videos
Predicting Molecular Geometry
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis IV: Nursing Management